Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL

Introduction: Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, is authorized for the treatment of chronic lymphocytic leukemia (CLL). This study aims to explore the cardiac safety profile of ibrutinib in comparison with obinutuzumab.Methods: A retrospective pharmacovigilance study was con...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Annamaria Mascolo (Author), Raffaella Di Napoli (Author), Nunzia Balzano (Author), Elena D'Alessio (Author), Imma Izzo (Author), Francesco Rossi (Author), Giuseppe Paolisso (Author), Annalisa Capuano (Author), Liberata Sportiello (Author)
Hōputu: Pukapuka
I whakaputaina: Frontiers Media S.A., 2023-08-01T00:00:00Z.
Ngā marau:
Urunga tuihono:Connect to this object online.
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ipurangi

Connect to this object online.

3rd Floor Main Library

Ngā taipitopito puringa mai i 3rd Floor Main Library
Tau karanga: A1234.567
Tārua 1 Wātea